Nonenzymatic Asn Deamidation of GAD65 Generates HLA-DRB1*03:01–Restricted Neoepitopes in Type 1 Diabetes
GAD65-reactive antibodies are common in individuals with DRB1*03:01 haplotypes and diabetes, and benefits from GAD65 therapy are linked to DRB1*03:01 genotypes. DRB1*03:01 prefers Asp in binding pocket 4, such that Asn deamidation, a modification documented in islets, could generate neoepitopes. DRB1*03:01 should present GAD65 epitopes, but few have been reported. We aimed to identify DRB1*03:01-restricted GAD65 epitopes recognized in individuals with type 1 diabetes (T1D). We defined wild-type and Asn-deamidated GAD65 epitopes that are bound by DRB1*03:01 and assessed their immunogenicity through in vitro T-cell assays. In total, three deamidated and four unmodified GAD65 peptides elicited detectable T-cell responses in individuals with T1D. T-cell clones and lines recognizing each GAD65 epitope were isolated and studied, demonstrating that Asn-deamidated GAD65 epitopes are recognized with higher affinity than unmodified GAD65 epitopes. Furthermore, islet-derived T cells from pancreatic organ donors with T1D recognized Asn-deamidated and unmodified GAD65 epitopes. In total, our work identifies wild-type and deamidated epitopes that drive GAD65-specific T-cell responses in individuals positive for DRB1*03:01. These epitopes can now be applied to characterize GAD65-specific T-cell responses during diabetes progression and in the setting of clinical trials. ARTICLE HIGHLIGHTS: DRB1*03:01 is associated with GAD65 autoantibodies and immune modulation with GAD65 protein, but few reliable epitopes have been reported. We aimed to identify relevant GAD65 epitopes recognized in individuals positive for DRB1*03:01. We identified regions of GAD65 that are recognized by CD4+ T cells in individuals with DRB1*03:01 haplotypes and type 1 diabetes, including wild-type and Asn-deamidated epitopes. T cells recognized deamidated GAD65 with higher affinity than wild-type GAD65. GAD65-specific T cells are present among islet-derived T cells from pancreatic organ donors, suggesting a direct role in islet autoimmunity.
Authors
- Erandi Velarde de la Cruz (ORCID: https://orcid.org/0000-0001-6985-8441)
- Anthony Manganaro
- Sally C. Kent (ORCID: https://orcid.org/0000-0002-1543-8086)
- Chantal Mathieu (ORCID: https://orcid.org/0000-0002-4055-5233)
- Eddie A. James (ORCID: https://orcid.org/0000-0002-7217-5729)
- Anthony R. Jones
- Aïsha Callebaut
- Lut Overbergh
Institutions
- University of Massachusetts Chan Medical School (US)
- Benaroya Research Institute (US)
- KU Leuven (BE)
Publication Details
- Journal
- Diabetes
- Published
- 2026-11-16
- DOI
- https://doi.org/10.2337/db26-0296
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00